The following is a summary of "Adherence and persistence among people with type 2 diabetes newly initiating oral semaglutide ...

Alogliptin (NESINA), a dipeptidyl peptidase IV (DPP-4) inhibitor, was approved by the FDA on January 25, 2013 to improve blood sugar control in adults with type 2 diabetes. This drug had been ...

Democratic Progressive Party (DPP) Legislator-at-large Hung Sun-han (洪申翰) has been chosen to succeed Ho Pei-shan (何佩珊) as ...

Major standardization associations and initiatives are partnering to create the best of breed system architecture to support ...

For patients with nephrolithiasis, sodium-glucose cotransporter-2 (SGLT-2) inhibitor use is associated with a reducti ...

President William Ruto on Thursday fired a warning to investigative agencies including the Director of Public Prosecutions ...

For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a lower risk for venous thromboembolism (VTE).

SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...

Three-fourths of U.S. adults are now overweight or have obesity, with nearly 260 million predicted to have overweight or ...

Japan's ruling coalition on Wednesday agreed with a key opposition party on the draft of an economic stimulus package, ...